Solitaire 4 Revascularization Device— 510(k) K183022
Substantially EquivalentMicro Therapeutics, Inc. d/b/a ev3 Neurovascular
FDA 510(k) clearance K183022 for Solitaire 4 Revascularization Device, Substantially Equivalent on 2019-01-29. Applicant: Micro Therapeutics, Inc. d/b/a ev3 Neurovascular.
Clearance details
- Applicant
- Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
- Product code
- Code POL
- Advisory panel
- Neurology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Irvine, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.